Compare DFLI & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DFLI | EDAP |
|---|---|---|
| Founded | 2020 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.4M | 75.5M |
| IPO Year | N/A | 1997 |
| Metric | DFLI | EDAP |
|---|---|---|
| Price | $3.51 | $3.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $22.50 | $8.50 |
| AVG Volume (30 Days) | ★ 1.0M | 67.0K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $57,783,000.00 | ★ $74,853,925.00 |
| Revenue This Year | $17.85 | N/A |
| Revenue Next Year | $30.29 | $2.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 18.24 | 0.61 |
| 52 Week Low | $1.50 | $1.21 |
| 52 Week High | $38.90 | $3.45 |
| Indicator | DFLI | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 67.37 | 64.25 |
| Support Level | $0.41 | $2.70 |
| Resistance Level | $4.23 | $3.45 |
| Average True Range (ATR) | 0.34 | 0.34 |
| MACD | 0.29 | 0.05 |
| Stochastic Oscillator | 64.44 | 86.28 |
Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a cost-effective storage solution.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.